Skip to content

Marino Garcia, CEO and President at Dianthus Therapeutics, sold DNTH on Aug 7, 2026

Data as of Oct 16

▼ SELL$11.2M104,091 shares at $107.96Marino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.
Watch DNTH
Traded
Aug 7, 2026
Disclosed
Aug 7, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Marino Garcia, CEO and President at Dianthus Therapeutics, sold DNTH on Aug 7, 2026TRADEDDISCLOSED
DNTHSimilar stocks (XLV — its sector index fund), rebased to DNTH's price on the disclosure day
DNTH since disclosure
−33.8%
after the sale
Similar stocks (XLV) since disclosure
+6.7%
XLV — its sector index fund

Change in closing price from Aug 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$279Kdisclosed Aug 7 · filed the same day
  2. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$259Kdisclosed Aug 7 · filed the same day
  3. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$2.6Mdisclosed Aug 7 · filed the same day
  4. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$2.4Mdisclosed Aug 7 · filed the same day
  5. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$88.6Kdisclosed Aug 7 · filed the same day
  6. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$1.1Mdisclosed Aug 7 · filed the same day

See every trade on DNTH →